Literature DB >> 19629749

Is tissue engineering a new paradigm in medicine? Consequences for the ethical evaluation of tissue engineering research.

Leen Trommelmans1, Joseph Selling, Kris Dierickx.   

Abstract

Ex-vivo tissue engineering is a quickly developing medical technology aiming to regenerate tissue through the introduction of an ex-vivo created tissue construct instead of restoring the damaged tissue to some level of functionality. Tissue engineering is considered by some as a new medical paradigm. We analyse this claim and identify tissue engineering's fundamental characteristics, focusing on the aim of the intervention and on the complexity and continuity of the process. We inquire how these features have an impact not only on the scientific research itself but also on the ethical evaluation of this research. We suggest that viewing tissue engineering as a new medical paradigm allows us to develop a wider perspective for successful investigation instead of focusing on isolated steps of the tissue engineering process in an anecdotal way, which may lead to an inadequate ethical evaluation. We argue that the concept of tissue engineering as a paradigm may benefit the way we address the ethical challenges presented by tissue engineering.

Mesh:

Year:  2009        PMID: 19629749     DOI: 10.1007/s11019-009-9192-0

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  87 in total

Review 1.  Stem cell research: immortality or a healthy old age?

Authors:  Christine Mummery
Journal:  Eur J Endocrinol       Date:  2004-11       Impact factor: 6.664

Review 2.  Functional tissue engineering parameters toward designing repair and replacement strategies.

Authors:  David L Butler; Jason T Shearn; Natalia Juncosa; Matthew R Dressler; Shawn A Hunter
Journal:  Clin Orthop Relat Res       Date:  2004-10       Impact factor: 4.176

3.  What lies at the interface of regenerative medicine and developmental biology?

Authors:  Donald E Ingber; Michael Levin
Journal:  Development       Date:  2007-06-06       Impact factor: 6.868

Review 4.  Updates on stem cells and their applications in regenerative medicine.

Authors:  Stefan Bajada; Irena Mazakova; James B Richardson; Nureddin Ashammakhi
Journal:  J Tissue Eng Regen Med       Date:  2008-06       Impact factor: 3.963

Review 5.  The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering.

Authors:  George T-J Huang; Wataru Sonoyama; Yi Liu; He Liu; Songlin Wang; Songtao Shi
Journal:  J Endod       Date:  2008-06       Impact factor: 4.171

Review 6.  Endothelial stem cells and precursors for tissue engineering: cell source, differentiation, selection, and application.

Authors:  Saejeong Kim; Horst von Recum
Journal:  Tissue Eng Part B Rev       Date:  2008-03       Impact factor: 6.389

Review 7.  Tissue engineering in cleft palate and other congenital malformations.

Authors:  Nicholas J Panetta; Deepak M Gupta; Bethany J Slater; Matthew D Kwan; Karen J Liu; Michael T Longaker
Journal:  Pediatr Res       Date:  2008-05       Impact factor: 3.756

8.  Informing participants in clinical trials with ex vivo human tissue-engineered products: what to tell and how to tell it?

Authors:  Leen Trommelmans; Joseph Selling; Kris Dierickx
Journal:  J Tissue Eng Regen Med       Date:  2008-06       Impact factor: 3.963

Review 9.  Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation.

Authors:  Catherine M Kolf; Elizabeth Cho; Rocky S Tuan
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 10.  Fetal and adult liver stem cells for liver regeneration and tissue engineering.

Authors:  H C Fiegel; Claudia Lange; U Kneser; W Lambrecht; A R Zander; X Rogiers; D Kluth
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

View more
  3 in total

1.  Towards a richer debate on tissue engineering: a consideration on the basis of NEST-ethics.

Authors:  A J M Oerlemans; M E C van Hoek; E van Leeuwen; S van der Burg; W J M Dekkers
Journal:  Sci Eng Ethics       Date:  2012-11-15       Impact factor: 3.525

2.  Stem cell trials for cardiovascular medicine: ethical rationale.

Authors:  Sophie L Niemansburg; Martin Teraa; Husna Hesam; Johannes J M van Delden; Marianne C Verhaar; Annelien L Bredenoord
Journal:  Tissue Eng Part A       Date:  2013-12-11       Impact factor: 3.845

3.  Ethics of Early Clinical Trials of Bio-Artificial Organs.

Authors:  Eline M Bunnik; Dide de Jongh; Emma Massey
Journal:  Transpl Int       Date:  2022-07-06       Impact factor: 3.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.